Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Minomic gives update on first-in-human study of MILGa

Jan. 10, 2017

Cerveau finalizes license agreement with Merck & Co. for tau imaging agent

Jan. 9, 2017

In vitro and in vivo evaluation of [18F]JNJ-64413739 PET tracer

Jan. 2, 2017

DMC recommends continuation of phase III trial of Progenics' 1404

Dec. 23, 2016

Discovery of novel pH transistor nanoprobe for cancer specific detection of malignant tumours

Dec. 23, 2016

First patient dosed in phase II/III trial of 18F-DCFPyL imaging agent

Dec. 9, 2016

Data validate SIME Dx's lung maturity test for identifying infants at risk of RDS

Nov. 28, 2016

Navidea signs Lymphoseek asset purchase agreement with Cardinal Health

Nov. 24, 2016

Aurora Diagnostics selected to provide Ventana PD-L1 Assay in U.S.

Nov. 16, 2016

CellMax-DNA Genetic Cancer Risk Test available in India

Nov. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026